Tiffany Hsu

The spliceosome is a therapeutic vulnerability in MYC-driven cancer

Tiffany Hsu, Lukas M. Simon, Nicholas J. Neill et al. · Nature · 2015 · 524 citations · Full text

Medicine, Molecular Biology, Oncology +14

MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

Atsushi Terunuma, Nagireddy Putluri, Prachi Mishra et al. · Journal of Clinical Investigation · 2013 · 470 citations · Full text

Medicine, Biochemistry, Oncology +17

A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis

Jessica D. Kessler, Kristopher T. Kahle, Tingting Sun et al. · Science · 2011 · 440 citations

Medicine, Molecular Biology, Oncology +17

Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot‘

Kristin M. D’Silva, Naomi Serling‐Boyd, Rachel Wallwork et al. · Annals of the Rheumatic Diseases · 2020 · 277 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +8

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Jeffrey A. Sparks, Zachary S. Wallace, Andrea M. Seet et al. · Annals of the Rheumatic Diseases · 2021 · 241 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15